The economic costs of Group B Streptococcus (GBS) disease: Prospective cohort study of infants with GBS disease in England

European Journal of Health Economics

Volumn 10, Issue 3, 2009, Pages 275-285

  Schroeder, Elizabeth Ann ^a   Petrou, Stavros ^a   Balfour, Gail ^b   Edamma, Oya ^a   Heath, Paul T ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Cohort study; Cost analysis; Group B Streptococcus; Health economics

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL CHARGE; HUMAN; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SOCIAL CARE; UNITED KINGDOM;

EID: 67649227150     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-008-0131-4     Document Type: Article

References (31)

1. van den Akker-van Marle, M.E., Rijnders, M.E.B., Fekkes, M., Amelink-Verburg, M.P., van Dommelen, P., Verkerk, P.H.: Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early onset group B streptococcal disease. Health Econ. 1, 85-92 (1992). doi: 10.1002/hec.4730010202
2. T Colbourn C Asseburg L Bojke Z Philips N Welton K Claxton 2007 Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses BMJ 335 655
3. C Stan M Boulvain PA Bovier M Aukenthaler Berner O Irion 2001 Choosing a strategy to prevent early onset group B streptococcal sepsis: economic evaluation Br. J. Obstet. Gynaecol. 108 840 847 (Pubitemid 32695318)
4. MR Law G Palmomaki Z Alfirevic R Gilbert P Heath C McCartney 2005 The prevention of neonatal group B streptococcal disease J. Med. Screen 12 2 60 68
5. Early Onset Group B Strep Infection in Newborns: Prevention and prophylaxis. Clinical Bulletin no. 2 January. http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&list-uids=9358702&dopt= Abstract (1997). Accessed 16 Sept 2004
6. Health Protection Agency: Group B Streptococcus. http://www.hpa.org.uk/ infections/topics-az/strepto/pyogenic/GroupB-Strep-FAQ.htm. Accessed 5 July 2006
7. S Oddie ND Emberton 2002 Risk factors for early onset group B streptococcal sepsis: case-control study BMJ 325 308
8. Group B Strep Support Group. http://www.gbss.org.uk/. Accessed 17 Nov 2006
9. P Heath G Balfour AM Weisner A Efstratiou TL Lamagni H Tighe 2004 Group B streptococcal disease in UK and Irish infants younger than 90 days Lancet 363 292 293
10. Easmon, C.S., Hastings, M.J., Clare, A.J., Bloxham, B., Marwood, R., Rivers, R.P., et al.: Nosocomial transmission of group B streptococci. Br. Med. J. (Clin. Res. Ed.). 283(6289), 459-461 (1981) (Pubitemid 11040284)
11. Royal College of Obstetrics and Gynaecologists: Prevention of early onset neonatal group B streptococcal disease. Guideline no. 36. http://www.rcog.org. uk/resources/public/pdf/neonatal-summary-050207a.pdf (2003). Accessed 19 Dec 2007
12. Early-Onset and Late-Onset Neonatal Group B Streptococcal Disease-United States, 1996-2004: Morb. Mortal. Wkly Rep. 2. 54(47), 1205-1208 (2005)
13. Nicoll, A., Heath, P.T.: Group B streptococcal infection. Arch. Dis. Child. Fetal. Neonatal. Ed. 82, F207 (2000)
14. National Institute for Health and Clinical Excellence (NICE): Guide to the Methods of Technology Appraisal. NICE, London (2004)
15. MF Drummond 1992 Cost-effectiveness guidelines for reimbursement of pharmaceutical: is economic evaluation ready for its enhanced status? Health Econ. 1 85 92
16. MF Drummond TO Jefferson 1996 Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ economic evaluation working party BMJ 313 275 283
17. Drummond, M.F., O'Brien, B., Stoddart, G.L., Torrance, G.W.: Methods for the economic evaluation of health care programmes, 3rd edn. Oxford University Press, Oxford (2005)
18. Netten, A., Curtis, L.: Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent (2003)
19. Allen, C., Beecham, J.: Costing services: ideals and reality. In: Netten, A., Beecham, J. (eds.) Costing Community Care: Theory and Practice, pp. 25-42. Ashgate, Aldershot (1995)
20. British Medical Association and Royal Pharmaceutical Society of Great Britain: British National Formulary (September). BMJ Books and Pharmaceutical Press, London (2000)
21. Treasury, H.M.: Value for Money Assessment Guidance. HM Treasury, London (2004)
22. A Briggs T Clark J Wolstenholme P Clarke 2003 Missingâ presumed at random: cost-analysis of incomplete data Health Econ. 12 5 377 392 (Pubitemid 36603549)
23. SG Thompson JA Barber 2000 How should cost data in pragmatic randomized trials be analyzed? BMJ 320 1197 1200 (Pubitemid 30224273)
24. Dixon, P.M.: The bootstrap and the jackknife: describing the precision of ecological indices. In: Design and Analysis of Ecological Experiments, pp. 290-318. Chapman and Hall, New York (1993)
25. AH Briggs DE Wonderling 1997 Pulling cost-effectiveness up by its bootstraps: a non-parametric approach to confidence interval estimation Health Econ. 6 4 327 340 (Pubitemid 27384638)
26. J Tucker W Tarnow-Mordi C Gould 1999 UK neonatal intensive care services in 1996. On behalf of the UK Neonatal Staffing Study Collaborative Group Arch. Dis. Child Fetal. Neonatal. Ed. 80 F233 F234
27. National Statistics Standard Occupational Classification 2000-SOC2000. http://www.statistics.gov.uk/methods-quality/ns-sec/soc2000.asp. Accessed 8 July 2002
28. CR Phares R Lynfield MM Farley J Mohle-Boetani 2008 Epidemiology of invasive Group B Streptococcal disease in the United States, 1999-2005 JAMA 299 17 2056 2065 (Pubitemid 351656587)
29. Department for Education and Skills: National Statistics Bulletin. Statistics of Education: education and training expenditure since 1993-1994. Available at: http://www.dfes.gov.uk/rsgateway/DB/SBU/b000406/index.shtml. Accessed 24 August 2002
30. A Sinha TA Lieu LC Paoletti MC Weinstein R Platt 2005 The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis Vaccine 23 3187 3195
31. S Petrou E Kupek C Hockley M Goldacre 2006 Social class inequalities in childhood mortality and morbidity in an English population Paediatr. Perinat. Epidemiol. 20 14 23